Copyright Reports & Markets. All rights reserved.

Global Gene Therapy for CNS Disorders Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Ex Vivo
      • 1.4.3 In Vivo
    • 1.5 Market by Application
      • 1.5.1 Global Gene Therapy for CNS Disorders Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gene Therapy for CNS Disorders Market Size
    • 2.2 Gene Therapy for CNS Disorders Growth Trends by Regions
      • 2.2.1 Gene Therapy for CNS Disorders Market Size by Regions (2014-2025)
      • 2.2.2 Gene Therapy for CNS Disorders Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Gene Therapy for CNS Disorders Market Size by Manufacturers
      • 3.1.1 Global Gene Therapy for CNS Disorders Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Gene Therapy for CNS Disorders Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Gene Therapy for CNS Disorders Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gene Therapy for CNS Disorders Key Players Head office and Area Served
    • 3.3 Key Players Gene Therapy for CNS Disorders Product/Solution/Service
    • 3.4 Date of Enter into Gene Therapy for CNS Disorders Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gene Therapy for CNS Disorders Market Size by Type (2014-2019)
    • 4.2 Global Gene Therapy for CNS Disorders Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Gene Therapy for CNS Disorders Market Size (2014-2019)
    • 5.2 Gene Therapy for CNS Disorders Key Players in United States
    • 5.3 United States Gene Therapy for CNS Disorders Market Size by Type
    • 5.4 United States Gene Therapy for CNS Disorders Market Size by Application

    6 Europe

    • 6.1 Europe Gene Therapy for CNS Disorders Market Size (2014-2019)
    • 6.2 Gene Therapy for CNS Disorders Key Players in Europe
    • 6.3 Europe Gene Therapy for CNS Disorders Market Size by Type
    • 6.4 Europe Gene Therapy for CNS Disorders Market Size by Application

    7 China

    • 7.1 China Gene Therapy for CNS Disorders Market Size (2014-2019)
    • 7.2 Gene Therapy for CNS Disorders Key Players in China
    • 7.3 China Gene Therapy for CNS Disorders Market Size by Type
    • 7.4 China Gene Therapy for CNS Disorders Market Size by Application

    8 Japan

    • 8.1 Japan Gene Therapy for CNS Disorders Market Size (2014-2019)
    • 8.2 Gene Therapy for CNS Disorders Key Players in Japan
    • 8.3 Japan Gene Therapy for CNS Disorders Market Size by Type
    • 8.4 Japan Gene Therapy for CNS Disorders Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gene Therapy for CNS Disorders Market Size (2014-2019)
    • 9.2 Gene Therapy for CNS Disorders Key Players in Southeast Asia
    • 9.3 Southeast Asia Gene Therapy for CNS Disorders Market Size by Type
    • 9.4 Southeast Asia Gene Therapy for CNS Disorders Market Size by Application

    10 India

    • 10.1 India Gene Therapy for CNS Disorders Market Size (2014-2019)
    • 10.2 Gene Therapy for CNS Disorders Key Players in India
    • 10.3 India Gene Therapy for CNS Disorders Market Size by Type
    • 10.4 India Gene Therapy for CNS Disorders Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gene Therapy for CNS Disorders Market Size (2014-2019)
    • 11.2 Gene Therapy for CNS Disorders Key Players in Central & South America
    • 11.3 Central & South America Gene Therapy for CNS Disorders Market Size by Type
    • 11.4 Central & South America Gene Therapy for CNS Disorders Market Size by Application

    12 International Players Profiles

    • 12.1 Gilead (Kite Pharma)
      • 12.1.1 Gilead (Kite Pharma) Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gene Therapy for CNS Disorders Introduction
      • 12.1.4 Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
      • 12.1.5 Gilead (Kite Pharma) Recent Development
    • 12.2 Amgen (BioVex)
      • 12.2.1 Amgen (BioVex) Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gene Therapy for CNS Disorders Introduction
      • 12.2.4 Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
      • 12.2.5 Amgen (BioVex) Recent Development
    • 12.3 Novartis
      • 12.3.1 Novartis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gene Therapy for CNS Disorders Introduction
      • 12.3.4 Novartis Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
      • 12.3.5 Novartis Recent Development
    • 12.4 Roche (Spark Therapeutics)
      • 12.4.1 Roche (Spark Therapeutics) Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gene Therapy for CNS Disorders Introduction
      • 12.4.4 Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
      • 12.4.5 Roche (Spark Therapeutics) Recent Development
    • 12.5 Bluebird Bio
      • 12.5.1 Bluebird Bio Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gene Therapy for CNS Disorders Introduction
      • 12.5.4 Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
      • 12.5.5 Bluebird Bio Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Gene Therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
      In 2018, the global Gene Therapy for CNS Disorders market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Gene Therapy for CNS Disorders status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy for CNS Disorders development in United States, Europe and China.

      The key players covered in this study
      Gilead (Kite Pharma)
      Amgen (BioVex)
      Novartis
      Roche (Spark Therapeutics)
      Bluebird Bio
      ...

      Market segment by Type, the product can be split into
      Ex Vivo
      In Vivo

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gene Therapy for CNS Disorders status, future forecast, growth opportunity, key market and key players.
      To present the Gene Therapy for CNS Disorders development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gene Therapy for CNS Disorders are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now